
Oncospace: AI-driven medical device manufacturer specializing in personalized radiation oncology treatments.
Oncospace, founded in 2019 and headquartered in Baltimore, Maryland, is a medical device manufacturing company specializing in radiation oncology. The company's core mission is to personalize each patient’s treatment using an AI-based platform, aiming to minimize side effects and maintain the quality of life. Oncospace offers a cloud-native, AI-powered data analytics platform that enables clinicians to predict achievable plans, promote best practice behaviors, and share expertise seamlessly. Their market focus is on optimizing outcomes for radiation oncology patients, practices, and communities.
Notable affiliated people and investors have not been disclosed. However, Oncospace has achieved significant milestones, including receiving FDA clearance for their head and neck treatment platform. The company's AI-driven approach has had a meaningful impact on the field of radiation oncology by enhancing the precision and personalization of treatments, thereby improving patient outcomes and advancing clinical practices.

Onc.AI
onc.ai

Oncora Medical
oncoramedical.com

Precision Health AI

Fuse Oncology
fuseonc.com

OncoPrecision
oncoprecision.bio

SegAna

Outcomes4Me

OncoLens
oncolens.com

VieCure
viecure.com

Oncodea
oncodea.com

GenomOncology
genomoncology.com

xCures
xcures.com

AIQ Solutions
aiq-solutions.com

Vysioneer
vysioneer.com

Irazu Oncology
irazuoncology.com
Companies similar to Oncospace include Onc.AI, Oncora Medical, Precision Health AI and Fuse Oncology.
Oncospace was founded in 2019.
Oncospace's headquarters is located in Baltimore, MD, US.
Oncospace's most recent funding round was for $1M (USD) in February 2021.
As of Feb 18, 2021, Oncospace has raised a total of $1.3M (USD).
Oncospace has 20 employees as of Feb 5, 2024.